Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SOLESENCE, INC.NANX · Entity 7041 | Director | December 31, 2024 | January 13, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SOLESENCE, INC.
Report date December 31, 2024 · Filed January 13, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.44 · Expires 2031-12-31 | Direct | 9,000 |
Reported balance
After 2024-12-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-12-31 · Grant · Acquired 9,000 · Balance 9,000 F1: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $1.24 · Expires 2030-07-19 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2024-12-31 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance 10,000 F1: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.61 · Expires 2030-12-27 | Direct | 12,600 |
Reported balance
Holding disclosure · report date 2024-12-31 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 12,600 F1: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
Filing footnotes · ownership attribution and instrument terms
F1: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2024 Filed Jan 13, 2025 22:11 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantCommon Stock (Right to Buy) · Derivative | 9,000 | $2.44 Strike: $2.44 | $21,960.00 |
DisclosureSEC source: 0000950170-25-004900 · ownership.xml · derivative · entry 3 Miller Mark E · CIK 0001985746 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2031-12-31 F1 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| December 27, 2023 Filed Dec 29, 2023 21:00 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantCommon Stock (option to purchase) · Derivative | 12,600 | $0.61 Strike: $0.61 | $7,686.00 |
DisclosureSEC source: 0001209191-23-059983 · doc4.xml · derivative · entry 2 Miller Mark E · CIK 0001985746 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,600 Underlying: Common Stock · 12,600 shares Expires 2030-12-27 F1 · derivative.exercise_date: Beginning on this date, and subject to certain restrictions, options vest in three equal annual installments. Read SEC document |
| July 19, 2023 Filed Jul 20, 2023 22:37 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantCommon Stock (option to purchase) · Derivative | 10,000 | $1.24 Strike: $1.24 | $12,400.00 |
DisclosureSEC source: 0001209191-23-042957 · doc4.xml · derivative · entry 1 Miller Mark E · CIK 0001985746 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-07-19 F1 · derivative.exercise_date: Beginning on this date, and subject to certain restrictions, options vest in three equal annual installments. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.